Turn Therapeutics (TTRX) Research & Development (2024 - 2026)

Turn Therapeutics' Research & Development history runs 3 years deep, the most recent figure standing at $109434.0 for Q1 2026.

• In Q1 2026, Research & Development rose 1081.92% year-over-year to $109434.0; the TTM figure through Mar 2026 stood at $340070.0 (changed N/A YoY), while the FY2025 annual figure was $265570.0, up 7.97% from the prior year.
• Research & Development for Q1 2026 stood at $109434.0, up from $62678.0 in the prior quarter.
• The five-year high for Research & Development was $158699.0 in Q3 2025, with the low at $9259.0 in Q1 2025.
• The 3-year median for Research & Development is $86056.0 (2025), against an average of $83853.0.
• The sharpest annual moves came in 2025 and 2026: Research & Development increased 3.53% in 2025, then jumped 1081.92% in 2026.
• Turn Therapeutics' Research & Development stood at $9766.0 in 2024, then jumped by 541.8% to $62678.0 in 2025, then soared by 74.6% to $109434.0 in 2026.
• Business Quant data shows TTRX's Research & Development at $109434.0 in Q1 2026, $62678.0 in Q4 2025, and $158699.0 in Q3 2025.